In this study, 127 sputum/tracheal aspirate specimens were evaluated by a laboratory-developed real-time RT-PCR method and Fusion SARS-CoV-2 assay. These specimens were collected from the patients who have nasopharyngeal swab (NPS) samples being used for SARS-CoV-2 detection previously or simultaneously. The overall agreement was 96% between the lower respiratory tract (LRT) and NPS samples, suggesting that LRT specimens could be an option for patients who develop a productive cough or those receiving invasive mechanical ventilation.

中文翻译：

---

通过实验室开发的测试和Panther Fusion系统分析用于SARS-CoV-2检测的痰/气管抽吸物和鼻咽样品

在这项研究中，通过实验室开发的实时RT-PCR方法和Fusion SARS-CoV-2测定法评估了127个痰/气管抽吸物标本。这些标本是从患者的鼻咽拭子（NPS）样本中先前或同时用于SARS-CoV-2检测的患者中收集的。下呼吸道（LRT）和NPS样本之间的总体一致性为96％，这表明LRT样本可以作为发生咳嗽或进行有创机械通气的患者的选择。